Search by Drug Name or NDC

    NDC 42023-0622-01 Bivalirudin 250 mg/1 Details

    Bivalirudin 250 mg/1

    Bivalirudin is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Par Pharmaceutical, Inc.. The primary component is BIVALIRUDIN.

    Product Information

    NDC 42023-0622
    Product ID 42023-622_795a02e6-0e33-4b66-8c68-0782006bcf1e
    Associated GPIs
    GCN Sequence Number 080076
    GCN Sequence Number Description bivalirudin VIAL 250MG/50ML INTRAVEN
    HIC3 M9E
    HIC3 Description THROMBIN INHIBITORS,SEL,DIRECT,REVERS-HIRUDIN TYPE
    GCN 46763
    HICL Sequence Number 021872
    HICL Sequence Number Description BIVALIRUDIN
    Brand/Generic Generic
    Proprietary Name Bivalirudin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Bivalirudin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name BIVALIRUDIN
    Labeler Name Par Pharmaceutical, Inc.
    Pharmaceutical Class Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA211215
    Listing Certified Through 2024-12-31

    Package

    NDC 42023-0622-01 (42023062201)

    NDC Package Code 42023-622-01
    Billing NDC 42023062201
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (42023-622-01) / 1 INJECTION, SOLUTION in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2023-06-19
    NDC Exclude Flag N
    Pricing Information N/A